Bradpharm Ltd

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—6

Registered number: 06548650

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Intangible Assets	4		268,750		376,250
Tangible Assets	5		147,965		153,456

			416,715		529,706
CURRENT ASSETS
Stocks	6	86,871		77,920
Debtors	7	247,263		232,342
Cash at bank and in hand		26,625		16,967

		360,759		327,229
Creditors: Amounts Falling Due Within One Year	8	(603,565 )		(640,001 )

NET CURRENT ASSETS (LIABILITIES)			(242,806 )		(312,772 )

TOTAL ASSETS LESS CURRENT LIABILITIES			173,909		216,934

Creditors: Amounts Falling Due After More Than One Year	9		(200,000 )		(200,000 )

NET (LIABILITIES)/ASSETS			(26,091 )		16,934

CAPITAL AND RESERVES
Called up share capital	10		2		2
Profit and Loss Account			(26,093 )		16,932

SHAREHOLDERS' FUNDS			(26,091)		16,934

Page 1

Page 2

Bradpharm Ltd

Balance Sheet (continued)

As At 30 September 2025

For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr P Buckley

Director

17/06/2026

The notes on pages 3 to 6 form part of these financial statements.

1. General Information

Bradpharm Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 06548650 . The registered office is Bradshaw Street Pharmacy Bradshaw Street, Orrell, Wigan, WN5 0AB.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

The turnover shown in the profit and loss account represents amounts receivable from the PCT for dispensary services and over the counter cash sales from the chemist shop operated by the company.

2.3. Intangible Fixed Assets and Amortisation - Goodwill

Goodwill is initially recorded at cost

It is amortised to Profit and Loss Account over its estimated economic life of 20 years.

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Freehold	2% Straight Line
Leasehold	15% Straight Line
Motor Vehicles	25% Straight Line
Fixtures & Fittings	15% Straight Line
Computer Equipment	25% Straight Line

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date with the recoverable amount being estimated where such indicators exist.When the carrying value exceeds the recoverable amount the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

2.5. Stocks and Work in Progress

Stocks are valued at cost using the latest cost price held by the professional stocktakers'. Obsolete stock is not included.

2.6. Financial Instruments

A financial asset or financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price.

2.7. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

...CONTINUED

Page 3

Page 4

Bradpharm Ltd

Notes to the Financial Statements (continued)

For The Year Ended 30 September 2025

2.7. Taxation - continued

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.

2.8. Pensions

The company operates a defined contribution pension scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.

2.9. Government Grant

Government grants are recognised in the profit and loss account in an appropriate manner that matches them with the expenditure towards which they are intended to contribute.

Grants for immediate financial support or to cover costs already incurred are recognised immediately in the profit and loss account. Grants towards general activities of the entity over a specific period are recognised in the profit and loss acount over that period.

Grants towards fixed assets are recognised over the expected useful lives of the related assets and are treated as deferred income and released to the profit and loss account over the useful life of the asset concerned.

All grants in the profit and loss account are recognised when all conditions for receipt have been complied with.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 15 (2024: 15)

4. Intangible Assets

	Goodwill
	£
Cost
As at 1 October 2024	2,150,000

As at 30 September 2025	2,150,000

Amortisation
As at 1 October 2024	1,773,750
Provided during the period	107,500

As at 30 September 2025	1,881,250

Net Book Value
As at 30 September 2025	268,750

As at 1 October 2024	376,250

Page 4

Page 5

Bradpharm Ltd

Notes to the Financial Statements (continued)

For The Year Ended 30 September 2025

5. Tangible Assets

	Land & Property
	Freehold	Leasehold	Motor Vehicles	Fixtures & Fittings
	£	£	£	£
Cost
As at 1 October 2024	172,276	1,295	7,248	224,367
Additions	-	-	-	-

As at 30 September 2025	172,276	1,295	7,248	224,367

Depreciation
As at 1 October 2024	28,107	1,295	7,248	222,047
Provided during the period	2,677	-	-	792

As at 30 September 2025	30,784	1,295	7,248	222,839

Net Book Value
As at 30 September 2025	141,492	-	-	1,528

As at 1 October 2024	144,169	-	-	2,320


	Computer Equipment	Total
	£	£
Cost
As at 1 October 2024	55,759	460,945
Additions	729	729

As at 30 September 2025	56,488	461,674

Depreciation
As at 1 October 2024	48,792	307,489
Provided during the period	2,751	6,220

As at 30 September 2025	51,543	313,709

Net Book Value
As at 30 September 2025	4,945	147,965

As at 1 October 2024	6,967	153,456

6. Stocks

	2025	2024
	£	£
Finished goods	86,871	77,920

Page 5

Page 6

Bradpharm Ltd

Notes to the Financial Statements (continued)

For The Year Ended 30 September 2025

7. Debtors

	2025	2024
	£	£
Due within one year
Trade debtors	161,245	149,228
Other debtors	86,018	83,114

	247,263	232,342

8. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Trade creditors	153,523	134,996
Other creditors	443,369	498,251
Taxation and social security	6,673	6,754

	603,565	640,001

9. Creditors: Amounts Falling Due After More Than One Year

	2025	2024
	£	£
Other creditors	200,000	200,000

10. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	2	2

Page 6